Modern management of menorrhagia

Journal of Family Planning and Reproductive Health Care

Volumn 30, Issue 2, 2004, Pages 118-122

  Protheroe, Joanne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIFIBRINOLYTIC AGENT; CONTRACEPTIVE AGENT; DANAZOL; ESTROGEN; ETAMSYLATE; GESTAGEN; GONADORELIN; IBUPROFEN; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; PROGESTERONE; TAMOXIFEN; TRANEXAMIC ACID;

ABDOMINAL HYSTERECTOMY; BREAST TENDERNESS; CLINICAL TRIAL; COCHRANE LIBRARY; CURETTAGE; DECISION MAKING; EMBASE; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYSTEROSCOPY; MEDLINE; MENORRHAGIA; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT SATISFACTION; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT OUTCOME; VAGINAL HYSTERECTOMY; VASCULAR FRAGILITY; VENOUS THROMBOEMBOLISM; WEIGHT GAIN;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATHETER ABLATION; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIUM; FEMALE; FIBRINOLYTIC AGENTS; GONADOTROPIN-RELEASING HORMONE; HORMONES; HUMANS; HYSTERECTOMY; MENORRHAGIA; MIDDLE AGED;

EID: 2442698985     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118904322995537     Document Type: Review

References (49)

1. Effective Health Care. The management of menorrhagia. Effective Health Care Bulletin 1995; 9: 1-14.
2. Duckitt K, Shaw R. Is medical management of menorrhagia obsolete? Br J Obstet Gynaecol 1998; 105: 569-572.
3. Coulter A, Kelland J, Peto V, et al. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995; 11: 456-471.
4. Tudor Hart J. What evidence do we need for evidence based medicine? J Epidemiol Community Health 1997; 51: 623-629.
5. Stirrat G, Choice of treatment for menorrhagia. Lancet 1999; 353: 2175-2176.
6. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, Issue 4, 2002. http://www.update-software.com [Accessed 9 November 2003].
7. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. The Cochrane Library, Issue 4, 2002. http://www.update-software.com [Accessed 9 November 2003].
8. Lethaby A, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. The Cochrane Library, Issue 4, 2002. http://www.update-software.com [Accessed 9 November 2003].
9. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. The Cochrane Library, Issue I, 2003. http://www.update-software.com [Accessed 9 November 2003].
10. Lethaby A, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding. The Cochrane Library, Issue 4, 2003. http://www.update-software.com [Accessed 9 November 2003].
11. Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand 2003; 82: 405-422.
12. Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss - a population study. Acta Obstet Gynecol Scand 1966; 45: 320-351.
13. Higham JM. Clinical associations with objective menstrual blood loss. Eur J Obstet Gynecol Reprod Biol 1999; 82: 73-76.
14. O'Flynn N, Britten N. Menorrhagia in general practice - disease or illness. Soc Sci Med 2000; 50: 651-661.
15. Royal College of Obstetricians and Gynaecologists (RCOG). The Initial Management of Menorrhagia. London, UK: RCOG, 1998.
16. Protheroe J. Communicating risk: but does it work, Doctor? BMJ 2003; 327: 1404.
17. Godolphin W. The role of risk communication in shared decision making. BMJ 2003; 327: 692-693.
18. Royal College of Obstetricians and Gynaecologists (RCOG). The Management of Menorrhagia in Secondary Care. London, UK: RCOG, 1999.
19. Vercellini P, Cortesi I, Oldani S, et al. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod 1997; 12: 1768-1771.
20. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510-1517.
21. Spencer CP, Whitehead MI. Endometrial assessment re-visited. Br J Obstet Gynaecol 1999; 106: 623-632.
22. Protheroe J. Management of menorrhagia in primary care. Womens Health Update 2001; 2: 1-3.
23. Adelantado JM, Rees MC, Lopez BA, et al. Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 1988; 95: 162-165.
24. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefanamic acid, and tranexamic acid. BMJ 1996; 313: 579-582.
25. Edlund M, Andersson K, Rybo G, et al. Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (kabi2161). Br J Obstet Gynaecol 1995; 102: 913-917.
26. Rybo G. Tranexamic acid therapy is effective treatment in heavy menstrual bleeding: clinical update on safety. Therapeutic Advances 1991; 4: 1-8.
27. Winkler UH. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2003; 99: 238-243.
28. Grover V, Usha R, Gupta U, et al. Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia Oceania J Obstet Gynaecol 1990; 16: 255-259.
29. Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol 1991; 31: 66-70.
30. Grant C, Gallier L, Fahey T, et al. Management of menorrhagia in primary care - impact on referral and hysterectomy: data from the Somerset morbidity project. J Epidemiol Community Health 2000; 54: 709-713.
31. Irvine GA, Campbell-Brown M, Lumsden MA, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998; 105: 592-598.
32. Bonduelle M, Walker JJ, Calder AA. A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia. Postgrad Med J 1991; 67: 833-836.
33. Crosignani PG, Vercellini P, Mosconi P, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997; 90: 257-263.
34. Lahteenmaki P, Haukkamaa M, Puolakka J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as an alternative to hysterectomy. BMJ 1998; 316: 1122-1126.
35. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001; 357: 273-277.
36. Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 1994; 11: 394-401.
37. Al-Kadri HM, Al-Turki HA, Saleh AM. Short and long term complications of abdominal and vaginal hysterectomy for benign disease. Saudi Med J 2002; 23: 806-810.
38. Benassi L, Rossi T, Kaihura CT, et al. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. Am J Obstet Gynecol 2002; 187: 1561-1565.
39. Carlson KJ. Outcomes of hysterectomy. Clin Obstet Gynecol 1997; 40: 939-946.
40. Meltomaa SS, Makinen JI, Taalikka MO, et al. One-year cohort of abdominal, vaginal, and laparoscopic hysterectomies: complications and subjective outcomes. J Am Coll Surg 1999; 189: 389-396.
41. O'Connor H, Broadbent JAM, Magos AL, et al. Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet 1997; 349: 897-901.
42. Ottosen C, Lingman G, Ottosen L. Three methods for hysterectomy: a randomised, prospective study of short term outcome. Br J Obstet Gynaecol 2000; 107: 1380-1385.
43. Wingo PA, Huezo CM, Rubin GL, et al. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985; 152: 803-808.
44. Pinion SB, Parkin DE, Abramovich DR, et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ 1994; 309: 979-983.
45. Sowter MC, Singla AA, Lethaby A. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; CD001124.
46. Corson SL, Brill AI, Brooks PG, et al. One-year results of the vesta systém for endometrial ablation. J Am Assoc Gynecol Laparosc 2000; 7: 489-497.
47. Coulter A, Peto V, Doll H. Patients' preferences and general practitioners' decisions in the treatment of menstrual disorders. Fam Pract 1994; 11: 67-74.
48. Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional endometrial bleeding: outcome at 4 years. Br J Obstet Gynaecol 1999; 106: 360-366.
49. Stewart A, Cummins C, Gold L, et al. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74-86.